Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 301,460 | 291,998 | 273,114 | 261,765 | 257,063 |
| Cost of Goods | 49,991 | 49,375 | 45,713 | 47,135 | 43,902 |
| Gross Profit | 251,469 | 242,623 | 227,401 | 214,630 | 213,161 |
| Operating Expenses | 201,318 | 199,869 | 192,222 | 183,408 | 181,695 |
| Operating Income | 51,142 | 43,129 | 35,892 | 31,357 | 32,368 |
| Interest Expense | 9 | 10 | 15 | 10 | 11 |
| Other Income | 397 | 872 | 519 | 700 | 471 |
| Pre-tax Income | 51,530 | 43,991 | 36,396 | 32,047 | 32,828 |
| Income Tax | 17,623 | 15,045 | 42,247 | 8,278 | 9,569 |
| Net Income Continuous | 33,907 | 28,946 | -5,851 | 23,769 | 23,259 |
| Net Income | $33,907 | $28,946 | $-5,851 | $23,769 | $23,259 |
| EPS Basic Total Ops | 1.40 | 1.20 | -0.23 | 0.98 | 0.95 |
| EPS Basic Continuous Ops | 1.40 | 1.20 | -0.23 | 0.98 | 0.95 |
| EPS Diluted Total Ops | 1.36 | 1.19 | -0.23 | 0.97 | 0.93 |
| EPS Diluted Continuous Ops | 1.37 | 1.19 | -0.22 | 0.97 | 0.93 |
| EBITDA(a) | $55,296 | $47,660 | $40,205 | $35,488 | $36,568 |